US equities
|
MU
$878.84
▼-5.63%
NVDA
$214.13
▼-1.43%
TSLA
$354.72
▼-2.13%
AAPL
$343.46
▲+0.43%
META
$709.33
▼-3.72%
MSFT
$529.05
▼-1.93%
SPCX
$146.03
▼-1.74%
AMD
$528.75
▼-5.95%
MU
$878.84
▼-5.63%
NVDA
$214.13
▼-1.43%
TSLA
$354.72
▼-2.13%
AAPL
$343.46
▲+0.43%
META
$709.33
▼-3.72%
MSFT
$529.05
▼-1.93%
SPCX
$146.03
▼-1.74%
AMD
$528.75
▼-5.95%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
CytomX Therapeutics, Inc. - Common Stock
(NQ:
CTMX
)
2.280
-0.130 (-5.39%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CytomX Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Buy Alert: 3 Penny Stocks That Will Explode in 2024
↗
June 05, 2024
Investors should consider these three penny stocks to buy before their success makes them more expensive to gain from.
Via
InvestorPlace
No Memes, Ma’am! Try a Sensible Biotech Bet With CytomX Therapeutics Stock.
↗
May 29, 2024
It's time to take CytomX Therapeutics stock seriously as CytomX Therapeutics forges a crucial partnership with a pharmaceutical powerhouse.
Via
InvestorPlace
Analysts' Varied Perspectives On CytomX's CX-904 Cancer Study: Safety Profile But Caution in Pancreatic Cancer
↗
May 09, 2024
Initial data from CytomX Therapeutics' CX-904 Phase 1a study shows safety and anti-cancer activity in heavily pretreated patients with advanced metastatic solid tumors. Reductions observed, especially...
Via
Benzinga
Gold Moves Higher; Roblox Issues Weak Outlook
↗
May 09, 2024
Via
Benzinga
SOUN Stock Alert: SoundHound AI Announces New Partnership With Perplexity
↗
May 09, 2024
SoundHound AI stock is slipping on Thursday as SOUN investors appear unimpressed by a new LLM collaboration with Perplexity.
Via
InvestorPlace
Topics
Artificial Intelligence
Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
May 09, 2024
Via
Benzinga
Dear NVDA Stock Fans, Mark Your Calendars for June 2
↗
May 09, 2024
Nvidia stock fans will want to keep an eye on the tech company when June 2 rolls around for a potential catalyst for NVDA shares.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
May 09, 2024
Via
Benzinga
Dow Jumps Over 150 Points; US Foods Posts Upbeat Earnings
↗
May 09, 2024
Via
Benzinga
Topics
Stocks
Why Is CytomX (CTMX) Stock Down 43% Today?
↗
May 09, 2024
CytomX Therapeutics stock is falling hard on Thursday after the company posted lackluster results in a cancer treatment clinical trial update.
Via
InvestorPlace
Why AppLovin Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
↗
May 09, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
May 09, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
May 09, 2024
Pre-market stock movers are a hot topic this morning and we've got traders covered with all of the news behind these movements on Thursday!
Via
InvestorPlace
CTMX Stock Earnings: CytomX Therapeutics Beats EPS, Beats Revenue for Q1 2024
↗
May 08, 2024
CTMX stock results show that CytomX Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
May 08, 2024
Via
Benzinga
Breaking on The Street Stocks To Watch Now! CTMX, PRSO, IMCC, KAVL, VTAK
May 03, 2024
Via
AB Newswire
Etsy Reports Downbeat Earnings, Joins Fastly, DoorDash And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
↗
May 02, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
May 02, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
May 02, 2024
Pre-market stock movers are worth checking out with our coverage of all the latest and greatest news happening on Thursday!
Via
InvestorPlace
Why Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket
↗
May 02, 2024
Via
Benzinga
Dow Jumps 200 Points Following Fed Decision; Pfizer Earnings Top Estimates
↗
May 01, 2024
Via
Benzinga
Topics
Economy
Stocks
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
May 01, 2024
Via
Benzinga
Crude Oil Down 3%; ISM Manufacturing PMI Falls In April
↗
May 01, 2024
Via
Benzinga
Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
May 01, 2024
Via
Benzinga
Cannabis Stocks CGC, ACB, TLRY Drop After Huge Rescheduling Rally
↗
May 01, 2024
Cannabis stocks are falling on Wednesday as shares of marijuana companies are giving up some of the massive gains they saw yesterday.
Via
InvestorPlace
Topics
Cannabis
What's Going On With CytomX Stock?
↗
May 01, 2024
CytomX Therapeutics shares are racing higher Wednesday. The company said it will report first-quarter results and provide an initial CX-904 Phase 1a dose escalation update on May 8, after the close of...
Via
Benzinga
Why Is CytomX (CTMX) Stock Up 180% Today?
↗
May 01, 2024
CytomX stock is rising higher on Wednesday as CTMX investors get an update on its upcoming earnings and clinical trial news.
Via
InvestorPlace
US Stocks Mixed; Amazon Posts Upbeat Earnings
↗
May 01, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
April 10, 2024
Via
Benzinga
Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
March 12, 2024
Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
